The first neighbors of NR1I2 (target of Paxlovid) are linked with colorectal carcinoma, obesity, Fanconi renotubular syndrome with maturity-onset diabetes of the young, thrombocytopenia, and cardiomyopathy. The gene discussed is NR1I2; the disease is type 2 diabetes mellitus.